Airway Therapeutics, LLC

CINCINNATI, OH · CIK 0001733867 · Biotech · Private

Immune-modulating biologic therapeutics targeting respiratory and inflammatory diseases, anchored by zelpultide alfa

airwaytherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$54M
2 Form D · Sep 2026
1 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$10,930,967
Private capital raisedForm D · SEC$43,496,282
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1744Iambic Therapeutics—$323M
1745AVT, Inc.—$170K
1746INFINIFLUIDICS INC——
1747Airway Therapeutics, LLC—$54M
1748Quoin Pharmaceuticals, Ltd.—$164M
1749Tempo Therapeutics Inc—$34M
1750ASAKE BIOTECHNOLOGY, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Jennifer DauerDirector
  • John RiceDirector
  • Marc SalzbergDirector · Executive Officer
  • Michael VenerableDirector

Patents

USPTO · 0 granted of 3
  • Methods And Compositions For Preparing Surfactant Protein D (sp-d)application
  • Methods And Compositions Comprising Surfactant Protein D (sp-d)application
  • Methods For Characterizing Surfactant Protein D (sp-d) Oligomersapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.